# Clinical Cases: Diabetes Mellitus - Pathophysiology

## Case 1: New-Onset Type 1 Diabetes with Diabetic Ketoacidosis

### Patient Demographics
- **Age:** 16 years
- **Sex:** Male
- **Occupation:** High school student

### Chief Complaint
"I've been drinking tons of water, going to the bathroom constantly, and I feel terrible."

### History of Present Illness
A 16-year-old previously healthy male presents to the emergency department with 3 weeks of progressive polyuria, polydipsia, and unintentional weight loss of 15 pounds despite increased appetite. Over the past 2 days, he has developed nausea, vomiting, and diffuse abdominal pain. Today, his parents noticed he appeared confused and was breathing rapidly. He has no prior medical history and takes no medications. Family history is notable for maternal aunt with type 1 diabetes and grandmother with autoimmune thyroid disease.

### Physical Examination
- **Vital Signs:** BP 98/60 mmHg, HR 118 bpm, RR 28 (deep, labored - Kussmaul breathing), Temp 37.0°C
- **General:** Thin, ill-appearing adolescent, lethargic but arousable
- **HEENT:** Dry mucous membranes, fruity odor on breath (acetone)
- **Cardiovascular:** Tachycardic, regular rhythm, weak pulses
- **Abdomen:** Diffuse tenderness without guarding or rigidity (metabolic, not surgical)
- **Skin:** Poor skin turgor, no acanthosis nigricans
- **Neurologic:** Oriented to person only, slowed responses

### Workup
- **Laboratory Studies:**
  - **Blood glucose:** 485 mg/dL (markedly elevated)
  - **Venous pH:** 7.12 (acidosis)
  - **Serum bicarbonate:** 8 mEq/L (low)
  - **Anion gap:** 28 (elevated; Na 132 - Cl 96 - HCO3 8 = 28)
  - **Serum ketones:** Large positive (beta-hydroxybutyrate 8.2 mmol/L)
  - **Potassium:** 5.8 mEq/L (elevated - but total body K+ depleted)
  - **Sodium:** 132 mEq/L (falsely low due to hyperglycemia)
  - **Corrected sodium:** 137 mEq/L
  - **BUN/Creatinine:** 32/1.6 (prerenal azotemia from dehydration)
  - **HbA1c:** 12.4% (indicates chronic hyperglycemia)
- **Autoantibody Panel:**
  - GAD65 antibodies: Positive
  - Islet cell antibodies (ICA): Positive
  - IA-2 antibodies: Positive
  - Insulin autoantibodies (IAA): Positive
- **C-peptide:** 0.3 ng/mL (low, indicating minimal endogenous insulin production)
- **Urinalysis:** Glucose 4+, ketones large

### Diagnosis
**Diabetic ketoacidosis (DKA)** as presenting manifestation of **Type 1 diabetes mellitus**

### Pathophysiology of DKA
1. **Absolute insulin deficiency** (autoimmune beta cell destruction) plus **counter-regulatory hormone excess** (glucagon, cortisol, epinephrine, growth hormone)
2. **Hyperglycemia:** Decreased glucose uptake + increased gluconeogenesis and glycogenolysis
3. **Osmotic diuresis:** Glucosuria causes polyuria, leading to dehydration and electrolyte losses
4. **Ketogenesis:** Insulin deficiency removes inhibition of lipolysis; free fatty acids flood liver and undergo beta-oxidation to ketone bodies (beta-hydroxybutyrate, acetoacetate, acetone)
5. **Metabolic acidosis:** Ketone bodies are acids, leading to anion gap metabolic acidosis
6. **Potassium shifts:** Acidosis and insulin deficiency cause K+ to shift extracellularly; serum K+ may be high despite total body depletion
7. **Abdominal pain:** Common in DKA, can mimic surgical abdomen

### Treatment
**DKA MANAGEMENT PROTOCOL:**

**1. FLUID RESUSCITATION:**
- 0.9% NS 15-20 mL/kg (1-1.5 L) over first hour
- Continue 0.9% NS at 250-500 mL/hr
- Switch to 0.45% NS when corrected Na normal or high
- Add D5 to fluids when glucose <200-250 mg/dL

**2. INSULIN THERAPY:**
- Regular insulin IV bolus 0.1 units/kg (optional)
- Regular insulin IV drip at 0.1 units/kg/hr
- Target glucose reduction: 50-75 mg/dL/hr
- Do NOT stop insulin until anion gap closes (even if glucose normalizes - add dextrose)

**3. POTASSIUM REPLACEMENT:**
- If K+ <3.3: Hold insulin, give K+ 20-40 mEq/hr aggressively
- If K+ 3.3-5.3: Add 20-30 mEq K+ to each liter of IV fluid
- If K+ >5.3: Do not add K+; recheck in 2 hours
- **Monitor closely** - K+ will drop rapidly with insulin therapy

**4. BICARBONATE:**
- Only if pH <6.9 (controversial, rarely needed)
- 100 mEq NaHCO3 in 400 mL water over 2 hours

**5. MONITORING:**
- Glucose hourly
- BMP every 2-4 hours
- Anion gap calculation with each BMP

**6. RESOLUTION CRITERIA:**
- Glucose <200-250 mg/dL
- Anion gap <12
- pH >7.3
- Bicarbonate ≥18 mEq/L

**7. TRANSITION TO SUBCUTANEOUS INSULIN:**
- Overlap IV and SQ insulin by 1-2 hours before stopping drip
- Start basal-bolus regimen: 0.5-0.75 units/kg/day
- Approximately 50% basal (glargine), 50% bolus (lispro with meals)

### Long-term Type 1 Diabetes Management
1. Lifelong insulin therapy (basal-bolus or insulin pump)
2. Carbohydrate counting and insulin-to-carb ratios
3. Self-monitoring of blood glucose or continuous glucose monitoring (CGM)
4. Target HbA1c <7% (individualized)
5. Diabetes education, nutrition counseling
6. Screen for complications annually after 5 years
7. Screen for associated autoimmune conditions (thyroid, celiac)

### Clinical Pearl
Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, leading to absolute insulin deficiency. Symptoms appear when ~90% of beta cells are destroyed, and patients often present with classic symptoms of polyuria, polydipsia, polyphagia, and weight loss. DKA occurs due to insulin deficiency combined with counter-regulatory hormone excess, resulting in uncontrolled lipolysis, ketogenesis, and metabolic acidosis. The presence of multiple autoantibodies (GAD65, IA-2, IAA, ZnT8) confirms the autoimmune etiology. In DKA management, the key principle is that insulin corrects the anion gap by stopping ketogenesis; therefore, insulin should continue until the gap closes, even if glucose normalizes (add dextrose to IV fluids). Potassium replacement is critical as total body potassium is depleted despite potentially normal or elevated serum levels, and K+ will drop rapidly with insulin therapy.

### Clinical Image
![Main Symptoms of Diabetes](case_01_image.jpg)

*Diagram illustrating the classic symptoms of diabetes mellitus including polyuria, polydipsia, polyphagia, and weight loss, along with the underlying metabolic derangements.*

**Image Source:** Wikimedia Commons - "Main symptoms of diabetes"
**License:** CC BY-SA 4.0
**URL:** https://commons.wikimedia.org/wiki/File:Main_symptoms_of_diabetes.svg

---

## Case 2: Type 2 Diabetes - Hyperosmolar Hyperglycemic State (HHS)

### Patient Demographics
- **Age:** 72 years
- **Sex:** Female
- **Occupation:** Retired, lives in assisted living facility

### Chief Complaint
"She's been confused and not herself for two days."

### History of Present Illness
A 72-year-old woman with type 2 diabetes, hypertension, and mild dementia is brought from her assisted living facility for altered mental status. Staff noted progressive lethargy over 2 days, decreased oral intake, and increased urination. She had a urinary tract infection treated with antibiotics 1 week ago but did not complete the course. Her diabetes has been controlled on metformin and glipizide. She has had polyuria and polydipsia for the past week, which staff attributed to drinking more fluids in warm weather. Her blood glucose this morning was "HI" (>600 mg/dL) on the facility glucometer.

### Physical Examination
- **Vital Signs:** BP 88/52 mmHg, HR 112 bpm, RR 18 (NOT Kussmaul), Temp 38.1°C
- **General:** Elderly woman, severely dehydrated, responsive only to painful stimuli
- **HEENT:** Extremely dry mucous membranes, sunken eyes
- **Cardiovascular:** Tachycardic, thready pulses
- **Abdomen:** Soft, non-tender
- **Skin:** Poor turgor, warm, dry
- **Neurologic:** Obtunded, localizes to pain, no focal deficits, sluggish pupils

### Workup
- **Laboratory Studies:**
  - **Blood glucose:** 892 mg/dL (extremely elevated)
  - **Serum osmolality:** 358 mOsm/kg (severely elevated, normal 275-295)
  - **Venous pH:** 7.31 (near normal - key difference from DKA)
  - **Serum bicarbonate:** 20 mEq/L (mildly low)
  - **Anion gap:** 14 (mildly elevated)
  - **Serum ketones:** Trace positive (minimal ketosis)
  - **Sodium:** 148 mEq/L (elevated, reflects severe dehydration)
  - **Corrected sodium:** 162 mEq/L (even higher when corrected for glucose)
  - **Potassium:** 4.8 mEq/L (total body depleted)
  - **BUN/Creatinine:** 68/2.8 (severe prerenal azotemia)
  - **HbA1c:** 9.8%
- **Urinalysis:** Glucose 4+, trace ketones, leukocyte esterase positive, nitrites positive (UTI)
- **Urine culture:** Pending
- **CT head:** No acute intracranial pathology

### Diagnosis
**Hyperosmolar hyperglycemic state (HHS)** precipitated by urinary tract infection

### Comparison: HHS vs DKA

| Feature | This Patient (HHS) | DKA |
|---------|-------------------|-----|
| Typical diabetes type | Type 2 | Type 1 |
| Glucose | 892 mg/dL (>600) | >250 mg/dL |
| Osmolality | 358 mOsm/kg (>320) | Variable |
| pH | 7.31 (>7.3) | <7.3 |
| Ketones | Trace | Significant |
| Mental status | Obtunded | Variable |
| Dehydration | Severe (8-12 L deficit) | Moderate |
| Mortality | Higher (10-20%) | Lower (1-5%) |

### Treatment
**HHS MANAGEMENT (Similar principles to DKA with important differences):**

**1. AGGRESSIVE FLUID RESUSCITATION (Most Critical):**
- 0.9% NS 15-20 mL/kg in first hour (1-1.5 L)
- Continue aggressive fluids - typical deficit 8-12 liters
- Goal: Replace 50% of deficit in first 12 hours
- Switch to 0.45% NS when corrected Na normal or high (usually needed)
- Fluids alone will significantly lower glucose

**2. INSULIN:**
- Start AFTER initial fluid bolus
- Lower rate than DKA: 0.05-0.1 units/kg/hr
- Target glucose reduction: 50-75 mg/dL/hr (NOT faster - risk of cerebral edema)
- Fluids contribute significantly to glucose lowering

**3. POTASSIUM:**
- Same replacement protocol as DKA
- Replace aggressively as K+ will drop with insulin and correction of acidosis

**4. MONITORING:**
- Glucose hourly
- Serum osmolality every 2-4 hours
- Mental status (should improve as osmolality normalizes)
- Neurologic checks for cerebral edema (avoid too-rapid correction)

**5. TREAT PRECIPITANT:**
- Antibiotics for UTI (ceftriaxone pending culture)
- Common precipitants: Infection, stroke, MI, medications

**6. RESOLUTION:**
- Osmolality <315 mOsm/kg
- Mental status returns to baseline
- Transition to SQ insulin and oral diabetes agents

### Pathophysiology of HHS
1. **Relative insulin deficiency:** Enough insulin to prevent ketosis but not hyperglycemia
2. **Gradual onset:** Develops over days to weeks (vs. hours to days in DKA)
3. **Severe hyperglycemia:** Causes massive osmotic diuresis
4. **Profound dehydration:** Often 8-12 L fluid deficit
5. **Hyperosmolarity:** Causes neurologic dysfunction; severity correlates with mental status
6. **Minimal ketosis:** Sufficient insulin prevents uncontrolled lipolysis
7. **Higher mortality:** Due to profound dehydration, older age, and comorbidities

### Clinical Pearl
HHS is characterized by extreme hyperglycemia (>600 mg/dL), hyperosmolarity (>320 mOsm/kg), and minimal ketosis, typically occurring in elderly patients with type 2 diabetes who have enough residual insulin to prevent ketogenesis but not hyperglycemia. Mental status changes correlate with serum osmolality. The key difference from DKA is the absence of significant ketoacidosis. Fluid resuscitation is the cornerstone of treatment - patients may have an 8-12 liter fluid deficit. Insulin is started at lower doses than DKA, and correction should be gradual to avoid cerebral edema. Mortality is higher than DKA (10-20%) due to older patient population, greater dehydration, and underlying comorbidities. Always identify and treat the precipitating factor, most commonly infection.

### Clinical Image
![Main Symptoms of Diabetes](case_01_image.jpg)

*Diagram showing the metabolic consequences of insulin deficiency and the classic symptoms of diabetes including polyuria, polydipsia, and weight loss that precede acute decompensation.*

**Image Source:** Wikimedia Commons - "Main symptoms of diabetes"
**License:** CC BY-SA 4.0
**URL:** https://commons.wikimedia.org/wiki/File:Main_symptoms_of_diabetes.svg

---